● Importantworld2 outlets covering this

The F.D.A. Approves a New Pill to Slash Cholesterol Levels

First publishedJul 16, 10:45 UTC

Last updatedJul 16, 12:05 UTC · 4m ago

2 outlets over time — hover a bar for its window & outletslast updated

The F.D.A. Approves a New Pill to Slash Cholesterol Levels

● Story signals

How strong is this topic?

7.5/10Significanceimpact & urgency

8.0/10Source trustoutlet authority

2Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

Merck’s cholesterol drug enlicitide, currently an injection prescribed by cardiologists, will be available as a daily pill prescribed by a primary care physician.

Reported by 2 outlets — NYT Home, CNBC Top News. See all sources ↓

Read the full report at NYT Home ↗

Why it matters

2 outlets are covering this world story — one to watch as reporting develops.

In brief

What's the story?: Merck’s cholesterol drug enlicitide, currently an injection prescribed by cardiologists, will be available as a daily pill prescribed by a primary care physician.
How widely is it covered?: 2 outlets, average source rating 8.0/10.
When was it last updated?: 4m ago.

Different angles across outlets

Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

Coverage card2 outlets
1Coverage
Scouting report
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
Sources2
TypeCoverage
NYT HomeJul 16, 10:45
CNBC Top NewsJul 16, 11:46

Related in the knowledge graph

organizationNew Pill organizationSlash Cholesterol Levels. Merck

Sources (2)

Avg source rating 8.0/10

Processing cluster

A1A2A3B1B2B3

Share this article

X / Twitter LinkedIn WhatsApp

Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)

GPT Perplexity Gemini Claude